{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:58:50Z","timestamp":1790179130877,"version":"4.1.0"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,22]],"date-time":"2011-06-22T00:00:00Z","timestamp":1308700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021411","type":"journal-article","created":{"date-parts":[[2011,6,22]],"date-time":"2011-06-22T21:03:41Z","timestamp":1308776621000},"page":"e21411","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye"],"prefix":"10.1371","volume":"6","author":[{"given":"Hu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley A.","family":"Vinores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.","volume":"118","author":"AP Adamis","year":"1994","journal-title":"Amer J Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.","volume":"331","author":"LP Aiello","year":"1994","journal-title":"New Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archopht.1994.01090230090028","article-title":"Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy.","volume":"112","author":"F Malecaze","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"ref4","first-page":"638","article-title":"Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.","volume":"72","author":"J Pe'er","year":"1995","journal-title":"Lab Invest"},{"key":"ref5","first-page":"574","article-title":"Vascular endothelial growth factor\/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.","volume":"145","author":"JW Miller","year":"1994","journal-title":"Am J Pathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization.","volume":"92","author":"EA Pierce","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.","volume":"359","author":"D Shweiki","year":"1992","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1050-1738(97)00091-1","article-title":"Ischemia-driven angiogenesis.","volume":"7","author":"Y Dor","year":"2000","journal-title":"Trends Cardiovasc Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-2952(99)00292-0","article-title":"Expression of hypoxia-inducible factor 1: mechanisms and consequences.","volume":"59","author":"GL Semenza","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1378\/chest.114.1_Supplement.40S","article-title":"Hypoxia-inducible factor 1: from molecular biology to cardiopulmonary physiology.","volume":"114","author":"GL Semenza","year":"1998","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jcp.20525","article-title":"Implication of the hypoxia response element of the VEGF promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.","volume":"206","author":"SA Vinores","year":"2006","journal-title":"J Cell Physiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/db09-1420","article-title":"M\u00fcller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage.","volume":"59","author":"J Wang","year":"2010","journal-title":"Diabetes"},{"key":"ref13","first-page":"281","article-title":"Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.","volume":"151","author":"N Okamoto","year":"1997","journal-title":"Am J Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0306-3623(01)00117-3","article-title":"Experimental models of growth factor-mediated angiogenesis and blood-retinal barrier breakdown.","volume":"35","author":"SA Vinores","year":"2002","journal-title":"General Pharmacology: The Vascular System"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"J Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cytogfr.2009.11.003","article-title":"Pathways mediating VEGF-independent tumor angiogenesis.","volume":"21","author":"N Ferrara","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0607542104","article-title":"Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis.","volume":"104","author":"MI Dorrell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine.","volume":"438","author":"P Carmeliet","year":"2005","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"15500","DOI":"10.1074\/jbc.M110.113787","article-title":"Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.","volume":"285","author":"A Kumar","year":"2010","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1167\/iovs.02-1092","article-title":"Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.","volume":"44","author":"JM Rakic","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","first-page":"467","article-title":"Anti-VEGF therapy for ocular vascular diseases. In: Angiogenesis: Basic Science and Clinical Applications, Maragoudakis ME &amp; Papadimitriou E editors.","volume":"28","author":"SA Vinores","year":"2007","journal-title":"Transworld Research Network, Kerala, India, Chapter"},{"key":"ref22","first-page":"849","article-title":"Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.","volume":"43","author":"AN Witmer","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"31273","DOI":"10.1074\/jbc.273.47.31273","article-title":"A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR\/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain.","volume":"273","author":"S Ogawa","year":"1998","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/emboj\/18.2.363","article-title":"A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.","volume":"18","author":"M Meyer","year":"1999","journal-title":"EMBO J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","article-title":"Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.","volume":"95","author":"S Hiratsuka","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.","volume":"7","author":"P Carmeliet","year":"2001","journal-title":"Nat Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.","volume":"8","author":"A Luttun","year":"2002","journal-title":"Nat Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2010.02.039","article-title":"Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease.","volume":"141","author":"S Van de Veire","year":"2010","journal-title":"Cell"},{"key":"ref29","first-page":"315","article-title":"Role of protein tyrosine kinase receptors in cancer: Possibilities for therapeutic intervention.","volume":"3","author":"P Rockwell","year":"1995","journal-title":"Mol Cell Diff"},{"key":"ref30","first-page":"5209","article-title":"Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.","volume":"59","author":"M Prewett","year":"1999","journal-title":"Cancer Res"},{"key":"ref31","first-page":"2893","article-title":"Targeting autocrine paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo.","volume":"104","author":"ES Wang","journal-title":"Blood 2004;"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1158\/1078-0432.CCR-06-0831","article-title":"Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.","volume":"12","author":"Y Wu","journal-title":"Clin Cancer Res 2006;"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1073\/pnas.191117498","article-title":"Inhibition of both paracrine and autocrine VEGF\/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.","volume":"98","author":"S Dias","journal-title":"Proc Natl Acad Sci USA 2001"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.exer.2004.11.019","article-title":"Identification of mouse retinal genes differentially regulated by dim and bright cyclic light rearing.","volume":"80","author":"H Huang","year":"2005","journal-title":"Exp Eye Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/dvdy.21408","article-title":"Developmental regulation of muscleblind-like (MBNL) gene expression in the chicken embryo retina.","volume":"237","author":"H Huang","year":"2008","journal-title":"Dev Dyn"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1096\/fj.00-0598fje","article-title":"Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development.","volume":"15","author":"GS Robinson","year":"2001","journal-title":"FASEB J"},{"key":"ref37","first-page":"492","article-title":"Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.","volume":"17","author":"XF Zhong","year":"2011","journal-title":"Mol Vis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1096\/fj.09-145664","article-title":"Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization.","volume":"24","author":"T Yoshida","year":"2010","journal-title":"FASEB J"},{"key":"ref39","first-page":"180","article-title":"Evolution of neovascularization in mice with overexpression of VEGF in photoreceptors.","volume":"39","author":"T Tobe","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref40","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse.","volume":"35","author":"LE Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis.","volume":"4","author":"KM Connor","year":"2009","journal-title":"Nat Protoc"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1167\/iovs.10-5576","article-title":"Parstatin suppresses ocular neovascularization and inflammation.","volume":"51","author":"H Huang","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref43","first-page":"2462","article-title":"Quantitative assessment of the integrity of the blood-retinal barrier in mice.","volume":"43","author":"NL Derevjanik","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref44","article-title":"Linear Mixed Models for Longitudinal Data.","author":"G Verbeke","year":"2000"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1167\/iovs.07-0113","article-title":"In vivo immunostaining demonstrates macrophages associated with growing and regressing vessels.","volume":"48","author":"J Shen","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1097-4652(200009)184:3<275::AID-JCP1>3.0.CO;2-7","article-title":"Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization.","volume":"184","author":"SF Hackett","year":"2000","journal-title":"J Cell Physiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.0702072104","article-title":"IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.","volume":"104","author":"KH Chang","year":"2007","journal-title":"Proc Nat'l Acad Sci USA"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1167\/iovs.08-2521","article-title":"Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.","volume":"50","author":"J Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e7945","DOI":"10.1371\/journal.pone.0007945","article-title":"Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD.","volume":"4","author":"W Ma","year":"2009","journal-title":"PLoS One 20;"},{"key":"ref50","article-title":"Recruitment of blood-derived inflammatory cells mediated via Tumor necrosis factor (TNF)-{alpha} receptor 1b exacerbates CNV.","author":"I Semkova","year":"2010"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/40.4.1372634","article-title":"Lectin staining of cultured CNS microglia.","volume":"40","author":"CA Colton","year":"1992","journal-title":"J Histochem Cytochem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/02713689308999475","article-title":"Isolation and culture of retinal microglia.","volume":"12","author":"RS Roque","year":"1993","journal-title":"Curr Eye Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm950","article-title":"An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.","volume":"9","author":"J Ambati","year":"2003","journal-title":"Nat Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1167\/iovs.09-4137","article-title":"Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization.","volume":"51","author":"N Sengupta","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1167\/iovs.09-3462","article-title":"The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages.","volume":"50","author":"UF Luhmann","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exer.2005.01.013","article-title":"Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization.","volume":"81","author":"A Caicedo","year":"2005","journal-title":"Exp Eye Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.mvr.2007.12.001","article-title":"SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation.","volume":"75","author":"E Guerin","year":"2008","journal-title":"Microvasc Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1167\/iovs.08-1760","article-title":"Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.","volume":"49","author":"D Maiti","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1158\/1535-7163.MCT-09-0554","article-title":"A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models.","volume":"9","author":"JL Brown","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1167\/iovs.07-0469","article-title":"Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761.","volume":"48","author":"Y Fu","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200868080-00002","article-title":"Neovascular age-related macular degeneration: potential therapies.","volume":"68","author":"AV Chappelow","year":"2008","journal-title":"Drugs"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0607542104","article-title":"Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis.","volume":"104","author":"MI Dorrell","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1517\/13543780903201684","article-title":"VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration.","volume":"18","author":"Dixon","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0079-6123(09)17517-9","article-title":"Treatment of retinal diseases with VEGF antagonists.","volume":"175","author":"Schlingemann","year":"2009","journal-title":"Prog Brain Res"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.survophthal.2009.02.003","article-title":"Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.","volume":"54","author":"J Tu\u00f1\u00f3n","year":"2009","journal-title":"Surv Ophthalmo l"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10456-008-9098-0","article-title":"Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies.","volume":"11","author":"RC Sainson","year":"2008","journal-title":"Angiogenesis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.","volume":"16","author":"JA Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1076\/ocii.10.1.27.10328","article-title":"Distribution, markers, and functions of retinal microglia.","volume":"10","author":"L Chen","year":"2002","journal-title":"Ocul Immunol Inflamm"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T15:45:04Z","timestamp":1589211904000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021411"}},"subtitle":[],"editor":[{"given":"Rajendra S.","family":"Apte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,22]]},"references-count":68,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021411","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,22]]}}}